GRAIL, Inc.

GRAL Nasdaq CIK: 0001699031

Company Information

Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1525 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Mailing Address 1525 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Phone (833) 694-2553
Fiscal Year End 1231
EIN 863673636

Financial Overview

FY2024

-$1.47B
Net Income
$3.91B
Total Assets
$479.90M
Total Liabilities
$2.50B
Stockholders' Equity
$241.60M
Cash & Equivalents
$-47.21
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 11, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 9, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
4 Insider stock transaction report December 5, 2025 View on SEC
4 Insider stock transaction report December 5, 2025 View on SEC
4 Insider stock transaction report December 5, 2025 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) November 24, 2025 View on SEC

Insider Trading

STRONG SELL 3 insiders 7 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8071)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.